The possible impact of dialysis modality on cognitive function in chronic dialysis patients

Netherlands Journal of Medicine

Volumn 68, Issue 4, 2010, Pages 153-157

  Radic J ^a   Ljutic D ^a   Radic M ^a   Kovacic V ^a   Sain M ^a   Dodig Curkovic K ^b  

^a UNIVERSITY HOSPITAL SPLIT   (Croatia)

^b University Hospital   (Croatia)

Author keywords

Chronic kidney disease; Cognitive function; Dialysis modality

Indexed keywords

ALBUMIN;

ALBUMIN BLOOD LEVEL; ANEMIA; CENTRAL NERVOUS SYSTEM; CHRONIC KIDNEY DISEASE; COGNITIVE DEFECT; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DISEASE SEVERITY; HEMODIALYSIS; HUMAN; HYPERVOLEMIA; INTERMETHOD COMPARISON; KIDNEY FAILURE; NONHUMAN; OUTCOME ASSESSMENT; PATIENT SATISFACTION; PUBLIC HEALTH PROBLEM; QUALITY OF LIFE; REVIEW; RISK FACTOR;

COGNITION DISORDERS; HUMANS; KIDNEY FAILURE, CHRONIC; RENAL DIALYSIS;

EID: 77951949360     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (67)

1. Fox CS, Larson MG, Vasan RS, et al. Cross-sectional association of kidney function with valvular and annular calcification: the Framingham heart study. J Am Soc Nephrol. 2006;17:521-7.
2. Nitsch D, Felber Dietrich D, von Eckardstein A, et al. Prevalence of renal impairment and its association with cardiovascular risk factors in a general population: results of the Swiss SAPALDIA study. Nephrol Dial Transplant. 2006;21:935-44.
3. Lindqvist R, Carlsson M, Sjödén PO. Coping strategies and health-related quality of life among spouses of continuous ambulatory peritoneal dialysis, haemodialysis, and transplant patients. J Adv Nurs. 2000;31:1398-408.
4. Maiorca R, Vonesh E, Cancarini GC, et al. A six-year comparison of patient and technique survivals in CAPD and HD. Kidney Int. 1988;34:518-24.
5. Serkes KD, Blagg CR, Nolph KD, Vonesh EF, Shapiro F. Comparison of patient and technique survival in continuous ambulatory peritoneal dialysis (CAPD) and hemodialysis: a multicenter study. Perit Dial Int. 1990;10:15-9.
6. Maiorca R, Vonesh EF, Cavalli P, et al. A multicenter selection- adjusted comparison of patient and technique survivals on CAPD and hemodialysis. Perit Dial Int. 1991;11:118-27.
7. Nelson CB, Port FK, Wolfe RA, Guire KE. Comparison of continuous ambulatory peritoneal dialysis and hemodialysis patient survival with evaluation of trends during the 1980s. J Am Soc Nephrol. 1992;3:1147-55.
8. Held PJ, Port FK, Turenne MN, et al. Continuous ambulatory peritoneal dialysis and hemodialysis: comparison of patient mortality and adjustment for co-morbid conditions. Kidney Int. 1994;45:1163-9.
9. Foley RN, Parfrey PS, Harnett JD, et al. Mode of dialysis therapy and mortality in end-stage renal disease. J Am Soc Nephrol. 1998;9:267-76.
10. Vonesh EF, Snyder JJ, Foley RN, Collins AJ. Mortality studies comparing peritoneal dialysis and hemodialysis: what do they tell us? Kidney Int Suppl. 2006;103:S3-11.
11. Unruh ML, Weisbord SD, Kimmel PL. Health-related quality of life in nephrology research and clinical practice. Semin Dial. 2005;18:82-90.
12. Schipper H, Clinch JJ, Olweny CLM. Quality of life studies: definitions and conceptual issues. In: B Spilker., editor. Quality of life and pharmacoeconomics in clinical trials. 2nd edition. Philadelphia: Lippincott-Raven Publishers; 1996. p. 11-24.
13. Thong MS, Kaptein AA. Quality of life in patients on peritoneal dialysis. In: Khanna R, Krediet RT, editors. Nolph and Gokal's Textbook of Peritoneal Dialysis. 3rd edition. USA: Springer; 2009. p. 21-50.
14. Barendse SM, Speight J, Bradley C. The Renal Treatment Satisfaction Questionnaire (RTSQ): a measure of satisfaction with treatment for chronic kidney failure. Am J Kidney Dis. 2005;45:572-9.
15. Rubin HR, Fink NE, Plantinga LC, Sadler JH, Kliger AS, Powe NR. Patient ratings of dialysis care with peritoneal dialysis vs hemodialysis. JAMA. 2004;291:697-703.
16. Juergensen E, Wuerth D, Finkelstein SH, Juergensen PH, Bekui A, Finkelstein FO. Hemodialysis and peritoneal dialysis: patients' assessment of their satisfaction with therapy and the impact of the therapy on their lives. Clin J Am Soc Nephrol. 2006;1:1191-6.
17. Ginieri-Coccossis M, Theofilou P, Synodinou C, Tomaras V, Soldatos C. Quality of life, mental health and health beliefs in haemodialysis and peritoneal dialysis patients: investigating differences in early and later years of current treatment. BMC Nephrol. 2008;14:9-14.
18. Cameron JL, Whiteside C, Katz J, Devins GM. Differences in quality of life across renal replacement therapies: A meta-analytic comparison. Am J Kidney Dis. 2000;35:29-37.
19. Evans RW, Manninen DL, Garrison LP Jr, et al. The quality of life of patients with end-stage renal disease. N Engl J Med. 1985;312:553-9.
20. Wasserfallen JB, Halabi G, Saudan P, et al. Quality of life on chronic dialysis: comparison between haemodialysis and peritoneal dialysis. Nephrol Dial Transplant. 2004;19:1594-9.
21. Merkus MP, Jager KJ, Dekker FW, Boeschoten EW, Stevens P, Krediet RT, (The NECOSAD Study Group). Quality of life in patients on chronic dialysis: Self-assessment 3 months after the start of treatment. Am J Kidney Dis. 1997;29:584-92.
22. Wuerth DB, Finkelstein SH, Schwetz O, Kliger AS, Finkelstein FO. Patients' descriptions of specific factors leading to modality selection of chronic peritoneal dialysis or haemodilysis. Perit Dial Int. 2002;22:184-90.
23. Wight JP, Edwards L, Brazier J, Walters S, Payne JN, Brown CB. The SF-36 as an outcome measure of services for end-stage renal failure. Qual Health Care. 1998;7:209-21.
24. Wu AW, Fink NE, Marsh-Manzi JV, et al. Changes in quality of life during haemodialysis and peritoneal dialysis treatment: Generic and disease specific measures. J Am Soc Nephrol. 2004;15:743-53.
25. Kutner NG, Zhang R, Barnhart H, Collins AJ. Health status and quality of life reported by incident patients after 1 year on haemodialysis or peritoneal dialysis. Nephrol Dial Transplant. 2005;20:2159-67.
26. Timmers L, Thong M, Dekker FW, et al. Illness perceptions in dialysis patients and their association with quality of life. Psychol Health. 2008;23:679-90.
27. Korevaar JC, Feith GW, Dekker FW, NECOSAD Study Group. Effect of starting with hemodialysis compared with peritoneal dialysis in patients new on dialysis treatment: a randomized controlled trial. Kidney Int. 2003;64:2222-8.
28. Souheaver GT, Ryan JJ, DeWolfe AS. Neuropsychological patterns in uremia. J Clin Psychol. 1982;38:490-6.
29. Hart RP, Pederson JA, Czerwinski AW, et al. Chronic renal failure, dialysis, and neuropsychological function. J Clin Neuropsychol. 1983;5:301-12.
30. Madero M, Gul A, Sarnak MJ. Cognitive function in chronic kidney disease. Semin Dial. 2008;21:29-37.
31. Kurella M, Chertow GM, Luan J, Yaffe K. Cognitive impairment in chronic kidney disease. J Am Geriatr Soc. 2004;52:1863-9.
32. Madan P, Kalra OP, Agarwal S, Tandon OP. Cognitive impairment in chronic kidney disease. Nephrol Dial Transplant. 2007;22:440-4.
33. Seghal AR, Grey SF, DeOreo PB, et al. Prevalence, recognition, and implications of mental impairment among hemodialysis patients. Am J Kidney Dis. 1997;41-49.
34. Burn DJ, Bates D. Neurology and the kidney. J Neurol Neurosurg Psychiatry. 1998;65:810-21.
35. Fazekas G, Fazekas F, Schmidt R, Kapeller P, Offenbacher H, Krejs GJ. Brain MRI findings and cognitive impairment in patients undergoing chronic hemodialysis treatment. J Neurol Sci. 1995;134:83-8.
36. Kamata T, Hishida A, Takita T, et al. Morphologic abnormalities in the brain of chronically hemodialyzed patients without cerebrovascular disease. Am J Nephrol. 2000;20:27-31.
37. Okada J, Yoshikawa K, Matsuo H, Kanno K, Oouchi M. Reversible MRI and CT findings in uremic encephalopathy. Neuroradiology. 1991;33:524-6.
38. Marsh JT, Brown WS, Wolcott D, et al. rHuEPO treatment improves brain and cognitive function of anemic dialysis patients. Kidney Int. 1991;39:155-63.
39. Johnston SC, O'Meara ES, Manolio TA, et al. Cognitive impairment and decline are associated with carotid artery disease in patients without clinically evident cerebrovascular disease. Ann Intern Med. 2004;140:237-47.
40. Burton EJ, Kenny RA, O'Brien J, et al. White matter hyperintensities are associated with impairment of memory, attention, and global cognitive performance in older stroke patients. Stroke. 2004;35:1270-5.
41. Yoshitake T, Kiyohara Y, Kato I, et al. Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama Study. Neurology. 1995;45:1161-8.
42. Desmond DW, Tatemichi TK, Paik M, Stern Y. Risk factors for cerebrovascular disease as correlates of cognitive function in a stroke-free cohort. Arch Neurol. 1993;50:162-6.
43. Gorelick PB, Brody J, Cohen D, et al. Risk factors for dementia associated with multiple cerebral infarcts. A case-control analysis in predominantly African-American hospital-based patients. Arch Neurol. 1993;50:714-20.
44. Morris MC, Evans DA, Bienias JL, Tangney CC, Wilson RS. Vitamin E and cognitive decline in older persons. Arch Neurol. 2002;59:1125-32.
45. Ikizler TA, Morrow JD, Roberts LJ, et al. Plasma F2-isoprostane levels are elevated in chronic hemodialysis patients. Clin Nephrol. 2002;58:190-7.
46. Wright CB, Lee HS, Paik MC, Stabler SP, Allen RH, Sacco RL. Total homocysteine and cognition in a tri-ethnic cohort: the Northern Manhattan Study. Neurology. 2004;63:254-60.
47. Mahoney CA, Arieff AI. Central and peripheral nervous system effects of chronic renal failure. Kidney Int. 1983;24:170-7.
48. Pereira AA, Weiner DE, Scott T, Sarnak MJ. Cognitive function in dialysis patients. Am J Kidney Dis. 2005;45:448-62.
49. Stivelman JC. Benefits of anaemia treatment on cognitive function. Nephrol Dial Transplant. 2000;15:29-35.
50. Murray AM. Cognitive impairment in the aging dialysis and chronic kidney disease populations: an occult burden. Adv Chronic Kidney Dis. 2008;15:123-32.
51. Appel GB, Blum CB, Chien S, et al. The hyperlipidemia of the nephrotic syndrome. Relation to plasma albumin concentration, oncotic pressure, and viscosity. New Engl J Med. 1985;312:1544-8.
52. Herrmann FR, Safran C, Levkoff SE, Minaker KL. Serum albumin level on admission as a predictor of death, length of stay, and readmission. Arch Intern Med. 1992;152:125-30.
53. Kutlay S, Nergizoglu G, Duman N, et al. Recognition of neurocognitive dysfunction in chronic hemodialysis patients. Ren Fail. 2001;23:781-7.
54. Pliskin NH, Yurk HM, Ho T, Umans JG. Neurocognitive function in chronic hemodialysis patients. Kidney Int. 1996;49:1435-40.
55. Umans JG, Pliskin NH. Attention and mental processing speed in hemodialysis patients. Am J Kidney Dis. 1998;32:749-51.
56. Dogukan A, Guler M, Yavuzkir MF, et al. The effect of strict volume control on cognitive functions in chronic hemodialysis patients. Ren Fail. 2009;31:641-6.
57. Kurella Tamura M, Wadley V, Yaffe K, et al. Kidney function and cognitive impairment in US adults: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Am J Kidney Dis. 2008;52:227-34.
58. Murray AM, Tupper DE, Knopman DS, et al.Cognitive impairment in hemodialysis patients is common. Neurology. 2006;67:216-23.
59. Thornton WL, Shapiro RJ, Deria S, Gelb S, Hill A. Differential impact of age on verbal memory and executive functioning in chronic kidney disease. J Int Neuropsychol Soc. 2007;13:344-53.
60. Elias MF, Elias PK, Seliger SL, Narsipur SS, Dore GA, Robbins MA. Chronic kidney disease, creatinine and cognitive functioning. Nephrol Dial Transplant. 2009;24:2446-52.
61. Kurella M, Mapes DL, Port FK, Chertow GM. Correlates and outcomes of dementia among dialysis patients: the Dialysis Outcomes and Practice Patterns Study. Nephrol Dial Transplant. 2006;21:2543-8.
62. Gokal R. Quality of life in patients undergoing renal replacement therapy. Kidney Int Suppl. 1993;40:S23-S27.
63. Sehgal AR, Grey SF, DeOreo PB, Whitehouse PJ. Prevalence, recognition and implications of mental impairment among hemodialysis patients. Am J Kidney Dis. 1997;30:41-9.
64. Saele K, Sønnesyn H, Svarstad E, Aarsland D. Cognitive failure in terminal kidney disease. Tidsskr Nor Laegeforen. 2009;129:296-9.
65. Wolcott DL, Wellisch DK, Marsh JT, Schaeffer J, Landsverk J, Nissenson AR. Relationship of dialysis modality and other factors to cognitive function in chronic dialysis patients. Am J Kidney Dis. 1988;12:275-84.
66. Buoncristiani U, Alberti A, Gubbiotti G, et al. Better preservation of cognitive faculty in continuous ambulatory peritoneal dialysis. Perit Dial Int. 1993;13:S202-S5.
67. Tilki HE, Akpolat T, Tunali G, Kara A, Onar MK. Effects of haemodialysis and continuous ambulatory peritoneal dialysis on P300 cognitive potentials in uraemic patients. Ups J Med Sci. 2004;109:43-8.